Area of research
Neurology · Psychiatry and Mental health
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments, and Neurological disorders and treatments.
Depressive Symptoms and Amyloid Pathology
Metabolic dysfunction-associated steatotic liver disease as a predictor of cognitive performance: An 11-year population-based follow-up study
APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly
Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease
Association of Midlife Inflammatory Markers With Cognitive Performance at 10-Year Follow-up
Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis
Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [<scp><sup>11</sup>C</scp>]<scp>PBR28</scp> and Machine Learning Analysis
Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells
Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)
Effects of age, BMI and sex on the glial cell marker TSPO — a multicentre [11C]PBR28 HRRT PET study
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
Midlife insulin resistance, <i>APOE</i> genotype, and late-life brain amyloid accumulation
PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample
Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition
Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
Prevalence of Amyloid PET Positivity in Dementia Syndromes
Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson’s disease
Long-Term Test–Retest Reliability of Striatal and Extrastriatal Dopamine D <sub>2/3</sub> Receptor Binding: Study with [ <sup>11</sup> C]Raclopride and High-Resolution PET
Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects
A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents
Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET
[11C]-MP4A PET Cholinergic Measurements in Amnestic Mild Cognitive Impairment, Probable Alzheimer's Disease, and Dementia with Lewy Bodies: A Bayesian Method and Voxel-Based Analysis